Wild-type IDH2 is a therapeutic target for triple-negative breast cancer
Article in Nature Communications (April 2024)
The most recent citing publications are shown below. View all 10,143 publications that cite this research output on Dimensions.
Article in Nature Communications (April 2024)
Article in Pathology International (April 2024)
Article in Cell Death & Disease (April 2024)